Document Details
Form
Filing Date
Jan 12, 2022
Document Date
Jan 10, 2022
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
EyePoint Pharmaceuticals
Issuer
EYEPOINT PHARMACEUTICALS, INC.